Skip to main content
Equibles
INTS logo

INTS · Intensity Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track INTS — free

Use INTS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INTS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.21 -0.16 (-4.75%) At close · Oct 1
Rebalance outlook locked
Going-concern doubt — flagged Aug 11, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on the cash and cash equivalents as of June 30, 2026, the Company's ability to continue its operations thereafter is dependent on obtaining additional capital, which is not within the Company's control. As a result, the Company believes there is substantial doubt about its ability to continue as a going concern.”
View the 10-Q filed Aug 11, 2026
Market Cap
$12.41M
Shares
3.26M
Volume · Oct 1 15.28K Avg daily vol (3M) 30.04K

Intensity Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Intensity Therapeutics, Inc. (INTS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Key facts CIK 1567264 CUSIP 45828J202 Visit website Investor relations